Komori
Earnings3001Katakura Industries Co.,Ltd.Materials and Chemicals

Second-quarter financial results for the fiscal year ending December 2026 [Japanese GAAP] (consolidated)

For the interim period of the fiscal year ending December 2026, revenue increased 0.4% year on year and operating profit increased 18.7%, improving earnings. The full-year earnings forecast was revised, but this financial results summary does not state the specific figures before and after the revision.

Worth reading
39Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
18.7
Year-on-year change in operating profit (%)
Wording
Conditional
How definitive the wording is.

Results for this period

Interim period (second quarter)1 January 2026–30 June 2026ConsolidatedJapanese GAAP
Net Sales20,834¥ millionYear on year +0.4%Progress 50.7%
Operating profit3,747¥ millionYear on year +18.7%Progress 64.6%
Ordinary income4,523¥ millionYear on year +16.9%Progress 62.8%
Net income attributable to owners of the parent5,371¥ millionYear on year +51.8%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share¥169.68
Financial position at period-end
Total assets152,352¥ million
of which net assets 102,040 ¥ millionEquity ratio 65.6%vs. prior year-end +1.8pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Cash inflows and outflows
Operating+4,958
Investment-1,094
Financials-3,149
Net change+715

Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.

Cash and cash equivalents at end of period¥13,118 million
Segment revenueReal Estate Business ¥6,019 million (YoY +6.0%), Pharmaceuticals Business ¥5,786 million (YoY +3.6%), Machinery-Related Business ¥4,197 million (YoY -12.1%), Textiles Business ¥3,467 million (YoY +4.0%), Other ¥1,364 million (YoY -1.2%)
Segment profitReal Estate Business ¥2,545 million (YoY +18.2%), Pharmaceuticals Business ¥454 million (YoY +1.6%), Machinery-Related Business ¥557 million (YoY -13.2%), Textiles Business ¥580 million (YoY +74.5%), Other ¥73 million (YoY -9.8%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥41,100 million (YoY +1.1%)
Operating profit¥5,800 million (YoY -0.9%)
Ordinary income¥7,200 million (YoY -0.2%)
Profit attributable to owners of the parent¥7,450 million (YoY +29.3%)
Revision to Earnings ForecastNet Sales Not disclosed → ¥41,100 million / Operating profit Not disclosed → ¥5,800 million / Ordinary income Not disclosed → ¥7,200 million / Profit attributable to owners of the parent Not disclosed → ¥7,450 million
Annual Dividend Forecast¥60 → ¥60(0.0%)
Factors Behind Changes in Business Performance

Although revenue declined in the machinery-related business, revenue increased due to higher revenue in the real estate, pharmaceutical and other businesses. Operating profit increased mainly because of higher profit in the real estate business, while interim net income attributable to owners of the parent increased due to the recognition of gains on sales of investment securities.

Disclosure regarding the going concern assumption

Not applicable (no matters to report in the notes on the going concern assumption)

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 0 companies / Excluded 0 companies / Company name None
Material subsequent eventsNo applicable matters.
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of investment securities ¥2,971 million / Extraordinary loss Not disclosed
Depreciation and amortization¥1,411 million
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingAvailable (for institutional investors and analysts)
Issued Shares at Period-End35,215,000
Treasury Shares at Period-End3,542,923
Results for this period
ItemDetails
Fiscal Period ClassificationInterim period (second quarter)
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedConsolidated
Period Covered1 January 2026–30 June 2026
Net Sales¥20,834 million (YoY +0.4%)
Operating profit¥3,747 million (YoY +18.7%)
Ordinary income¥4,523 million (YoY +16.9%)
Profit attributable to owners of the parent¥5,371 million (YoY +51.8%)
Net income per share¥169.68
Equity ratioEnd of the current fiscal period 65.6 / End of previous period 63.8
Total assets¥152,352 million
Net assets¥102,040 million
Cash flows from operating activities¥4,958 million
Cash flows from investing activities¥-1,094 million
Cash flows from financing activities¥-3,149 million
Cash and cash equivalents at end of period¥13,118 million
Full-year earnings forecastNet Sales ¥41,100 million (YoY +1.1%) / Operating profit ¥5,800 million (YoY -0.9%) / Ordinary income ¥7,200 million (YoY -0.2%) / Profit attributable to owners of the parent ¥7,450 million (YoY +29.3%)
Revision to Earnings ForecastNet Sales Not disclosed → ¥41,100 million / Operating profit Not disclosed → ¥5,800 million / Ordinary income Not disclosed → ¥7,200 million / Profit attributable to owners of the parent Not disclosed → ¥7,450 million
Annual Dividend Forecast¥60 → ¥60(0.0%)
Segment revenueReal Estate Business ¥6,019 million (YoY +6.0%), Pharmaceuticals Business ¥5,786 million (YoY +3.6%), Machinery-Related Business ¥4,197 million (YoY -12.1%), Textiles Business ¥3,467 million (YoY +4.0%), Other ¥1,364 million (YoY -1.2%)
Segment profitReal Estate Business ¥2,545 million (YoY +18.2%), Pharmaceuticals Business ¥454 million (YoY +1.6%), Machinery-Related Business ¥557 million (YoY -13.2%), Textiles Business ¥580 million (YoY +74.5%), Other ¥73 million (YoY -9.8%)
Depreciation and amortization¥1,411 million
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of investment securities ¥2,971 million / Extraordinary loss Not disclosed
Disclosure regarding the going concern assumptionNot applicable (no matters to report in the notes on the going concern assumption)
Change in accounting policyChanges due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No
Changes in the scope of consolidationNew 0 companies / Excluded 0 companies / Company name None
Material subsequent eventsNo applicable matters.
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingAvailable (for institutional investors and analysts)
Issued Shares at Period-End35,215,000
Treasury Shares at Period-End3,542,923
Factors Behind Changes in Business PerformanceAlthough revenue declined in the machinery-related business, revenue increased due to higher revenue in the real estate, pharmaceutical and other businesses. Operating profit increased mainly because of higher profit in the real estate business, while interim net income attributable to owners of the parent increased due to the recognition of gains on sales of investment securities.
Items this document does not state (6)
Operating MarginPayout ratioShareholder Return PolicyRegional salesOrders received and order backlogImpairment loss

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Although revenue declined in the machinery-related business, revenue increased in the real estate, pharmaceutical and other businesses. Operating profit increased mainly because of higher profit in the real estate business, while interim net income attributable to owners of the parent increased due to the recognition of gains on sales of investment securities.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Second-quarter financial results for the fiscal year ending December 2026 [Japanese GAAP] (consolidated) | Katakura Industries Co.,Ltd. (3001) timely disclosure | Komori